Valensa Expands Astaxanthin Extraction Capacity

Thu Feb 14, 2008 7:50am EST

* Reuters is not responsible for the content in this press release.

Growing Demand for High-Quality Finished Product that Meets Regulatory &
Health Issues and New Strategic Alliance Create Conditions for Expansion

ORLANDO, Fla., Feb. 14 /PRNewswire/ -- Valensa International announced
today that it has increased its capacity for the extraction of Haematococcus
pluvialis for the manufacture of finished all-natural astaxanthin. The move
was made in light of recently growing demand for a high-quality astaxanthin in
North America, Asia and Europe that is both pesticide-free and allergen-free -
two conditions that are only possible with select raw material sources and
extraction facilities. In addition to market demand, a recently formed
Strategic Alliance with Cyanotech Corporation (Kona, HI), where Valensa
provides extraction services of raw material provided by Cyanotech, will
require increased capacity to facilitate orderly growth of supply for the
market and increased uptake of Valensa's own ZANTHIN(R) natural astaxanthin
brand. The capacity expansion will be approximately 20% and will be achieved
primarily through manufacturing efficiencies and de-bottlenecking its
facilities in Eustis, Florida, USA. The expansion will include new facilities
for screening biomass against the presence of pesticides. Astaxanthin products
extracted at Valensa's Eustis facility will be certified pesticide- and
allergen-free.
    According to Dr. Rudi Moerck, President of Valensa, high-quality
astaxanthin biomass and strict quality control in manufacturing are the two
key elements for creating a finished astaxanthin product that meets or exceeds
the quality and regulatory requirements of world markets. "There is growing
interest and excitement about the potential of astaxanthin - the world's most
potent antioxidant with clinical trial data indicating support in areas such
as eye health, neurological health, immune support, inflammation reduction and
skin health. Recently, the demand for a high-quality, pesticide-free source of
the product has outstripped supply. The Strategic Alliance that we have formed
with Cyanotech Corporation and our move to increase extraction capacity will
help meet market requirements for this growing demand," he said. "Valensa has
provided extraction services to Cyanotech for some time now and we were
impressed by their biomass purity and pesticide-free profile," he said. "Our
company has previously qualified a number of astaxanthin biomass sources, but
product purity and overall product integrity led us to choose Cyanotech as our
principal algae biomass supplier." Valensa's ZANTHIN(R) natural astaxanthin
product has been marketed in the United States for over a decade and was the
first astaxanthin extract to have Novel Foods approval in the European Union
in July 2004. "These approvals require a pesticide-free, solvent-free and
allergen-free astaxanthin. By qualifying our suppliers and screening our raw
materials, through the use of supercritical carbon dioxide extraction
technology and through our superior quality management, we are uniquely
positioned to deliver the astaxanthin products required by world markets,"
said Dr. Moerck.
    For further information, contact:
    Dr. Rudi Moerck, President
    Voice: 352-357-2004
    Fax: 352-483-2095
    http://www.valensa.com


    This release was issued through eReleases(TM).  For more information,
visit http://www.ereleases.com.
SOURCE  Valensa International

Dr. Rudi Moerck, President of Valensa International, +1-352-357-2004, Fax:
+1-352-483-2095
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.